查处“血友病医保诈骗”，也应看到患者用药之痛

Group 1 - The core issue revolves around the conflict between the medical consensus on preventive treatment for hemophilia and the current reimbursement policies that only cover treatment after bleeding occurs [2][3][4] - The case highlights a significant number of defendants involved in a healthcare fraud scheme, including over 50 individuals from various roles such as medical representatives, private hospitals, and pharmacies [1] - The prosecution argues that the fraudulent activities undermine the integrity of the healthcare insurance system, which is based on the principle of "funds for specific purposes" and "actual occurrence" [1] Group 2 - There is a pressing need for the healthcare reimbursement system to adapt to advancements in medical practices, particularly in preventive care, to avoid forcing patients into illegal actions for necessary treatments [2][3] - The establishment of a more rigorous diagnostic and regulatory framework is essential to differentiate between genuine medical needs and fraudulent claims, potentially utilizing objective evidence for treatment justification [3][4] - The ongoing evolution of the healthcare reimbursement policies must ensure flexibility and timely updates to align with clinical practices, thereby preventing similar disputes in the future [4]